The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen–glycosaminoglycan scaffold in vivo

This paper demonstrates a method to engineer, in vitro, a nascent microvasculature within a collagen–glycosaminoglycan scaffold with a view to overcoming the major issue of graft failure due to avascular necrosis of tissue-engineered constructs. Human umbilical vein endothelial cells (ECs) were cult...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta biomaterialia 2013-12, Vol.9 (12), p.9303-9316
Hauptverfasser: McFadden, T.M., Duffy, G.P., Allen, A.B., Stevens, H.Y., Schwarzmaier, S.M., Plesnila, N., Murphy, J.M., Barry, F.P., Guldberg, R.E., O’Brien, F.J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9316
container_issue 12
container_start_page 9303
container_title Acta biomaterialia
container_volume 9
creator McFadden, T.M.
Duffy, G.P.
Allen, A.B.
Stevens, H.Y.
Schwarzmaier, S.M.
Plesnila, N.
Murphy, J.M.
Barry, F.P.
Guldberg, R.E.
O’Brien, F.J.
description This paper demonstrates a method to engineer, in vitro, a nascent microvasculature within a collagen–glycosaminoglycan scaffold with a view to overcoming the major issue of graft failure due to avascular necrosis of tissue-engineered constructs. Human umbilical vein endothelial cells (ECs) were cultured alone and in various co-culture combinations with human mesenchymal stem cells (MSCs) to determine their vasculogenic abilities in vitro. Results demonstrated that the delayed addition of MSCs to pre-formed EC networks, whereby MSCs act as pericytes to the nascent vessels, resulted in the best developed vasculature. The results also demonstrate that the crosstalk between ECs and MSCs during microvessel formation occurs in a highly regulated, spatio-temporal fashion, whereby the initial seeding of ECs results in platelet derived growth factor (PDGF) release; the subsequent addition of MSCs 3days later leads to a cessation in PDGF production, coinciding with increased vascular endothelial cell growth factor expression and enhanced vessel formation. Functional assessment of these pre-engineered constructs in a subcutaneous rat implant model demonstrated anastomosis between the in vitro engineered vessels and the host vasculature, with significantly increased vascularization occurring in the co-culture group. This study has thus provided new information on the process of in vitro vasculogenesis within a three-dimensional porous scaffold for tissue engineering and demonstrates the potential for using these vascularized scaffolds in the repair of critical sized bone defects.
doi_str_mv 10.1016/j.actbio.2013.08.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1449272343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1742706113004066</els_id><sourcerecordid>1449272343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-574bc0c529cf02fb92d1d29d9c885d73c5536ec81f2f44890963d83f5dde9b963</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEoqXwBgi8ZJPgnzhxNkioooBUiQXt2vLY1zMeHHuwk0HDqu_As_BCPAmO0rJk5Wv5O-de31NVLwluCCbd232j9LRxsaGYsAaLBpP2UXVORC_qnnfican7ltY97shZ9SznPcZMECqeVmeUDbxw7Lz6fbMDZMCrExikjHGTiwFFi3bzqAIaIUPQu9OoPMoTjEiD9xlNER0S1DamscggmDjtwLsCLe8owPQjpm8ZJciznzJyAdk56MW7MEeV9exVcj_VQzeFdPRebSH8ufu19ScdsxpdiEtZxshaWRu9WYyO7hifV0-s8hle3J8X1e3Vh5vLT_X1l4-fL99f15qJbqp532401pwO2mJqNwM1xNDBDFoIbnqmOWcdaEEstW0rBjx0zAhmuTEwbMrlonqz-h5S_D5DnuTo8vJFFSDOWZK2HWhPWcsK2q6oTjHnBFYekhtVOkmC5RKY3Ms1MLkEJrGQJbAie3XfYd6UXf4TPSRUgNcrYFWUaptclrdfiwPHmOCBdLwQ71YCyiaODpLM2pXUwLgEepImuv_P8BfJUbhW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449272343</pqid></control><display><type>article</type><title>The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen–glycosaminoglycan scaffold in vivo</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>McFadden, T.M. ; Duffy, G.P. ; Allen, A.B. ; Stevens, H.Y. ; Schwarzmaier, S.M. ; Plesnila, N. ; Murphy, J.M. ; Barry, F.P. ; Guldberg, R.E. ; O’Brien, F.J.</creator><creatorcontrib>McFadden, T.M. ; Duffy, G.P. ; Allen, A.B. ; Stevens, H.Y. ; Schwarzmaier, S.M. ; Plesnila, N. ; Murphy, J.M. ; Barry, F.P. ; Guldberg, R.E. ; O’Brien, F.J.</creatorcontrib><description>This paper demonstrates a method to engineer, in vitro, a nascent microvasculature within a collagen–glycosaminoglycan scaffold with a view to overcoming the major issue of graft failure due to avascular necrosis of tissue-engineered constructs. Human umbilical vein endothelial cells (ECs) were cultured alone and in various co-culture combinations with human mesenchymal stem cells (MSCs) to determine their vasculogenic abilities in vitro. Results demonstrated that the delayed addition of MSCs to pre-formed EC networks, whereby MSCs act as pericytes to the nascent vessels, resulted in the best developed vasculature. The results also demonstrate that the crosstalk between ECs and MSCs during microvessel formation occurs in a highly regulated, spatio-temporal fashion, whereby the initial seeding of ECs results in platelet derived growth factor (PDGF) release; the subsequent addition of MSCs 3days later leads to a cessation in PDGF production, coinciding with increased vascular endothelial cell growth factor expression and enhanced vessel formation. Functional assessment of these pre-engineered constructs in a subcutaneous rat implant model demonstrated anastomosis between the in vitro engineered vessels and the host vasculature, with significantly increased vascularization occurring in the co-culture group. This study has thus provided new information on the process of in vitro vasculogenesis within a three-dimensional porous scaffold for tissue engineering and demonstrates the potential for using these vascularized scaffolds in the repair of critical sized bone defects.</description><identifier>ISSN: 1742-7061</identifier><identifier>EISSN: 1878-7568</identifier><identifier>DOI: 10.1016/j.actbio.2013.08.014</identifier><identifier>PMID: 23958783</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Angiography ; Animals ; Blood Vessels - pathology ; Cattle ; cell growth ; Co-culture ; coculture ; Coculture Techniques ; Collagen - pharmacology ; Collagen–GAG scaffold ; Endothelial cells ; Glycosaminoglycans - pharmacology ; human umbilical vein endothelial cells ; Human Umbilical Vein Endothelial Cells - cytology ; Humans ; In vivo vascularization ; Mesenchymal stem cells ; Mesenchymal Stromal Cells - cytology ; Microscopy, Fluorescence, Multiphoton ; necrosis ; Neovascularization, Physiologic - drug effects ; Platelet-Derived Growth Factor - metabolism ; Rats ; Staining and Labeling ; stem cells ; tissue engineering ; Tissue Scaffolds - chemistry ; Vascular Endothelial Growth Factor A - metabolism ; X-Ray Microtomography</subject><ispartof>Acta biomaterialia, 2013-12, Vol.9 (12), p.9303-9316</ispartof><rights>2013 Acta Materialia Inc.</rights><rights>Copyright © 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-574bc0c529cf02fb92d1d29d9c885d73c5536ec81f2f44890963d83f5dde9b963</citedby><cites>FETCH-LOGICAL-c386t-574bc0c529cf02fb92d1d29d9c885d73c5536ec81f2f44890963d83f5dde9b963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.actbio.2013.08.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23958783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McFadden, T.M.</creatorcontrib><creatorcontrib>Duffy, G.P.</creatorcontrib><creatorcontrib>Allen, A.B.</creatorcontrib><creatorcontrib>Stevens, H.Y.</creatorcontrib><creatorcontrib>Schwarzmaier, S.M.</creatorcontrib><creatorcontrib>Plesnila, N.</creatorcontrib><creatorcontrib>Murphy, J.M.</creatorcontrib><creatorcontrib>Barry, F.P.</creatorcontrib><creatorcontrib>Guldberg, R.E.</creatorcontrib><creatorcontrib>O’Brien, F.J.</creatorcontrib><title>The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen–glycosaminoglycan scaffold in vivo</title><title>Acta biomaterialia</title><addtitle>Acta Biomater</addtitle><description>This paper demonstrates a method to engineer, in vitro, a nascent microvasculature within a collagen–glycosaminoglycan scaffold with a view to overcoming the major issue of graft failure due to avascular necrosis of tissue-engineered constructs. Human umbilical vein endothelial cells (ECs) were cultured alone and in various co-culture combinations with human mesenchymal stem cells (MSCs) to determine their vasculogenic abilities in vitro. Results demonstrated that the delayed addition of MSCs to pre-formed EC networks, whereby MSCs act as pericytes to the nascent vessels, resulted in the best developed vasculature. The results also demonstrate that the crosstalk between ECs and MSCs during microvessel formation occurs in a highly regulated, spatio-temporal fashion, whereby the initial seeding of ECs results in platelet derived growth factor (PDGF) release; the subsequent addition of MSCs 3days later leads to a cessation in PDGF production, coinciding with increased vascular endothelial cell growth factor expression and enhanced vessel formation. Functional assessment of these pre-engineered constructs in a subcutaneous rat implant model demonstrated anastomosis between the in vitro engineered vessels and the host vasculature, with significantly increased vascularization occurring in the co-culture group. This study has thus provided new information on the process of in vitro vasculogenesis within a three-dimensional porous scaffold for tissue engineering and demonstrates the potential for using these vascularized scaffolds in the repair of critical sized bone defects.</description><subject>Angiography</subject><subject>Animals</subject><subject>Blood Vessels - pathology</subject><subject>Cattle</subject><subject>cell growth</subject><subject>Co-culture</subject><subject>coculture</subject><subject>Coculture Techniques</subject><subject>Collagen - pharmacology</subject><subject>Collagen–GAG scaffold</subject><subject>Endothelial cells</subject><subject>Glycosaminoglycans - pharmacology</subject><subject>human umbilical vein endothelial cells</subject><subject>Human Umbilical Vein Endothelial Cells - cytology</subject><subject>Humans</subject><subject>In vivo vascularization</subject><subject>Mesenchymal stem cells</subject><subject>Mesenchymal Stromal Cells - cytology</subject><subject>Microscopy, Fluorescence, Multiphoton</subject><subject>necrosis</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Platelet-Derived Growth Factor - metabolism</subject><subject>Rats</subject><subject>Staining and Labeling</subject><subject>stem cells</subject><subject>tissue engineering</subject><subject>Tissue Scaffolds - chemistry</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>X-Ray Microtomography</subject><issn>1742-7061</issn><issn>1878-7568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhSMEoqXwBgi8ZJPgnzhxNkioooBUiQXt2vLY1zMeHHuwk0HDqu_As_BCPAmO0rJk5Wv5O-de31NVLwluCCbd232j9LRxsaGYsAaLBpP2UXVORC_qnnfican7ltY97shZ9SznPcZMECqeVmeUDbxw7Lz6fbMDZMCrExikjHGTiwFFi3bzqAIaIUPQu9OoPMoTjEiD9xlNER0S1DamscggmDjtwLsCLe8owPQjpm8ZJciznzJyAdk56MW7MEeV9exVcj_VQzeFdPRebSH8ufu19ScdsxpdiEtZxshaWRu9WYyO7hifV0-s8hle3J8X1e3Vh5vLT_X1l4-fL99f15qJbqp532401pwO2mJqNwM1xNDBDFoIbnqmOWcdaEEstW0rBjx0zAhmuTEwbMrlonqz-h5S_D5DnuTo8vJFFSDOWZK2HWhPWcsK2q6oTjHnBFYekhtVOkmC5RKY3Ms1MLkEJrGQJbAie3XfYd6UXf4TPSRUgNcrYFWUaptclrdfiwPHmOCBdLwQ71YCyiaODpLM2pXUwLgEepImuv_P8BfJUbhW</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>McFadden, T.M.</creator><creator>Duffy, G.P.</creator><creator>Allen, A.B.</creator><creator>Stevens, H.Y.</creator><creator>Schwarzmaier, S.M.</creator><creator>Plesnila, N.</creator><creator>Murphy, J.M.</creator><creator>Barry, F.P.</creator><creator>Guldberg, R.E.</creator><creator>O’Brien, F.J.</creator><general>Elsevier Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen–glycosaminoglycan scaffold in vivo</title><author>McFadden, T.M. ; Duffy, G.P. ; Allen, A.B. ; Stevens, H.Y. ; Schwarzmaier, S.M. ; Plesnila, N. ; Murphy, J.M. ; Barry, F.P. ; Guldberg, R.E. ; O’Brien, F.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-574bc0c529cf02fb92d1d29d9c885d73c5536ec81f2f44890963d83f5dde9b963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Angiography</topic><topic>Animals</topic><topic>Blood Vessels - pathology</topic><topic>Cattle</topic><topic>cell growth</topic><topic>Co-culture</topic><topic>coculture</topic><topic>Coculture Techniques</topic><topic>Collagen - pharmacology</topic><topic>Collagen–GAG scaffold</topic><topic>Endothelial cells</topic><topic>Glycosaminoglycans - pharmacology</topic><topic>human umbilical vein endothelial cells</topic><topic>Human Umbilical Vein Endothelial Cells - cytology</topic><topic>Humans</topic><topic>In vivo vascularization</topic><topic>Mesenchymal stem cells</topic><topic>Mesenchymal Stromal Cells - cytology</topic><topic>Microscopy, Fluorescence, Multiphoton</topic><topic>necrosis</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Platelet-Derived Growth Factor - metabolism</topic><topic>Rats</topic><topic>Staining and Labeling</topic><topic>stem cells</topic><topic>tissue engineering</topic><topic>Tissue Scaffolds - chemistry</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>X-Ray Microtomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McFadden, T.M.</creatorcontrib><creatorcontrib>Duffy, G.P.</creatorcontrib><creatorcontrib>Allen, A.B.</creatorcontrib><creatorcontrib>Stevens, H.Y.</creatorcontrib><creatorcontrib>Schwarzmaier, S.M.</creatorcontrib><creatorcontrib>Plesnila, N.</creatorcontrib><creatorcontrib>Murphy, J.M.</creatorcontrib><creatorcontrib>Barry, F.P.</creatorcontrib><creatorcontrib>Guldberg, R.E.</creatorcontrib><creatorcontrib>O’Brien, F.J.</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta biomaterialia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McFadden, T.M.</au><au>Duffy, G.P.</au><au>Allen, A.B.</au><au>Stevens, H.Y.</au><au>Schwarzmaier, S.M.</au><au>Plesnila, N.</au><au>Murphy, J.M.</au><au>Barry, F.P.</au><au>Guldberg, R.E.</au><au>O’Brien, F.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen–glycosaminoglycan scaffold in vivo</atitle><jtitle>Acta biomaterialia</jtitle><addtitle>Acta Biomater</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>9</volume><issue>12</issue><spage>9303</spage><epage>9316</epage><pages>9303-9316</pages><issn>1742-7061</issn><eissn>1878-7568</eissn><abstract>This paper demonstrates a method to engineer, in vitro, a nascent microvasculature within a collagen–glycosaminoglycan scaffold with a view to overcoming the major issue of graft failure due to avascular necrosis of tissue-engineered constructs. Human umbilical vein endothelial cells (ECs) were cultured alone and in various co-culture combinations with human mesenchymal stem cells (MSCs) to determine their vasculogenic abilities in vitro. Results demonstrated that the delayed addition of MSCs to pre-formed EC networks, whereby MSCs act as pericytes to the nascent vessels, resulted in the best developed vasculature. The results also demonstrate that the crosstalk between ECs and MSCs during microvessel formation occurs in a highly regulated, spatio-temporal fashion, whereby the initial seeding of ECs results in platelet derived growth factor (PDGF) release; the subsequent addition of MSCs 3days later leads to a cessation in PDGF production, coinciding with increased vascular endothelial cell growth factor expression and enhanced vessel formation. Functional assessment of these pre-engineered constructs in a subcutaneous rat implant model demonstrated anastomosis between the in vitro engineered vessels and the host vasculature, with significantly increased vascularization occurring in the co-culture group. This study has thus provided new information on the process of in vitro vasculogenesis within a three-dimensional porous scaffold for tissue engineering and demonstrates the potential for using these vascularized scaffolds in the repair of critical sized bone defects.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23958783</pmid><doi>10.1016/j.actbio.2013.08.014</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1742-7061
ispartof Acta biomaterialia, 2013-12, Vol.9 (12), p.9303-9316
issn 1742-7061
1878-7568
language eng
recordid cdi_proquest_miscellaneous_1449272343
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Angiography
Animals
Blood Vessels - pathology
Cattle
cell growth
Co-culture
coculture
Coculture Techniques
Collagen - pharmacology
Collagen–GAG scaffold
Endothelial cells
Glycosaminoglycans - pharmacology
human umbilical vein endothelial cells
Human Umbilical Vein Endothelial Cells - cytology
Humans
In vivo vascularization
Mesenchymal stem cells
Mesenchymal Stromal Cells - cytology
Microscopy, Fluorescence, Multiphoton
necrosis
Neovascularization, Physiologic - drug effects
Platelet-Derived Growth Factor - metabolism
Rats
Staining and Labeling
stem cells
tissue engineering
Tissue Scaffolds - chemistry
Vascular Endothelial Growth Factor A - metabolism
X-Ray Microtomography
title The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen–glycosaminoglycan scaffold in vivo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T16%3A50%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20delayed%20addition%20of%20human%20mesenchymal%20stem%20cells%20to%20pre-formed%20endothelial%20cell%20networks%20results%20in%20functional%20vascularization%20of%20a%20collagen%E2%80%93glycosaminoglycan%20scaffold%20in%20vivo&rft.jtitle=Acta%20biomaterialia&rft.au=McFadden,%20T.M.&rft.date=2013-12-01&rft.volume=9&rft.issue=12&rft.spage=9303&rft.epage=9316&rft.pages=9303-9316&rft.issn=1742-7061&rft.eissn=1878-7568&rft_id=info:doi/10.1016/j.actbio.2013.08.014&rft_dat=%3Cproquest_cross%3E1449272343%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1449272343&rft_id=info:pmid/23958783&rft_els_id=S1742706113004066&rfr_iscdi=true